For instance, Tan et al. studied 368 individuals with PTEN mutation and showed that risks of developing colorectal and kidney cancers began around the age of 40, with a lifetime risk of 9 and 34% respectively [33]. This evidence concerns the gene PTEN and kidney cancer.